Stoke Therapeutics, Inc. (STOK) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.12 | +92.7% |
| 2024 | $-1.65 | +30.7% |
| 2023 | $-2.38 | +8.5% |
| 2022 | $-2.60 | -11.1% |
| 2021 | $-2.34 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.12 | +92.7% |
| 2024 | $-1.65 | +30.7% |
| 2023 | $-2.38 | +8.5% |
| 2022 | $-2.60 | -11.1% |
| 2021 | $-2.34 | — |